Evidence map›Paper›PMID 35573863›Full record

ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2022

Association of the Coronavirus Disease 2019 Outbreak on the Diabetes Self-Management in Chinese Patients: An Analytical Cross-Sectional Study.

Linyan Huang, Li Zhang, Shuiping Jiang, Baozhu Liang, Ningning Xu, Jingxin Li, Xiaoyan Zhang, Zhen Zhang

Open access · goldAbstract read
In one paragraph

Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Linyan Huang *Department of Endocrinology, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
Li Zhang *Department of Endocrinology, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
Shuiping JiangDepartment of Endocrinology, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
Baozhu LiangDepartment of Endocrinology, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
Ningning XuDepartment of Endocrinology, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
Jingxin LiDepartment of Endocrinology, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
Xiaoyan ZhangDepartment of Endocrinology, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
Zhen ZhangDepartment of Endocrinology, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
Southern Medical University · CNZhujiang Hospital · CNGuangdong Provincial People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The coronavirus disease 2019 (COVID-19) outbreak has seriously affected people's lives, especially those with chronic diseases. Diabetes self-management, which plays an important role in glycaemic control and reducing the risk of acute and long-term complications, may be discouraged by social distancing. Purpose: To evaluate the level of self-management activities in Chinese patients with type 2 diabetes mellitus (T2DM) during the COVID-19 pandemic. Patients and Methods: A survey of with 872 patients with T2DM in the inpatient and outpatient departments through face-to-face interviews was conducted from 1 July, 2020 to 30 September, 2020. The main outcome measures were glycaemic control status and level of self-management activities during the pandemic. Results: In terms of glycaemic control, the data showed that patients with fasting plasma glucose (FPG) < 7.0 mmol/L (36.4%), postprandial plasma glucose (PPG) < 10.0 mmol/L (26.3%), or glycosylated haemoglobin (HbA1c) < 7.0% (18.6%) in our investigation has well-controlled blood glucose level, and 11.9% of patients experienced blood glucose <3.9 mmol/L during the outbreak. The diabetes self-management of Chinese patients decreased and the final diabetes self-management score of the Chinese patients was 3.4 ± 1.45. Patients with higher education, diabetes education, comorbidities, and online consultations had higher diabetes self-management scores ( Conclusion: The COVID-19 pandemic has affected diabetes self-management, including substandard glycemic control, increased diabetes-related stress, limited exercise range and medical visits. Therefore, future interventions should focus on the online management of chronic diseases and support online consultation' development and promotion, which can overcome physical distance and provide personalized services conveniently.

Indexed as

coronavirus disease 2019diabetes self-managementonline consultationtype 2 diabetes mellitus

Identifiers

PMID35573863
PMCPMC9094639
OpenAlexW4229055389

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.